U.S. Infrastructure Stock News

NasdaqGS:BIIB
NasdaqGS:BIIBBiotechs

Biogen (BIIB) And The Alzheimer’s Narrative As Valuation Stays In Focus

Biogen (BIIB) is back in focus after recent share price moves and fresh attention on its neurology focused drug portfolio. Investors are weighing current performance metrics against the company’s latest collaborations and therapy approvals. See our latest analysis for Biogen. At a share price of US$221.56, Biogen has shown firm momentum, with a 1 month share price return of 10.81%, year to date share price return of 24.60%, and a 1 year total shareholder return of 59.41%, despite weaker total...
NasdaqGS:GT
NasdaqGS:GTAuto Components

Why Goodyear Tire & Rubber (GT) Is Getting Attention Today

Goodyear Tire & Rubber (GT) has been active in two very different arenas. The company launched its Ultra Grip tractor tire and a Farm Experience Center in India, while also pushing harder into premium EV and luxury SUV tire segments. See our latest analysis for Goodyear Tire & Rubber. These product moves come as Goodyear Tire & Rubber trades at US$5.99, with the share price return down 17.27% over 30 days but slightly up 2.04% over 90 days. The 1 year total shareholder return has declined...
NasdaqGM:JANX
NasdaqGM:JANXBiotechs

Is Janux Therapeutics (JANX) Narrowing Losses Enough To Shift Its Long-Term Risk Profile?

Janux Therapeutics, Inc. reported past second-quarter and six-month 2026 results showing a reduced net loss of US$21.97 million and US$46.33 million, respectively, alongside lower basic loss per share than a year earlier. The narrowing losses suggest Janux is managing its cost base or revenue mix more efficiently, which may influence how investors assess its progress toward financial sustainability. With earnings showing a smaller net loss year-on-year, we’ll now explore what this means for...
NYSE:ATO
NYSE:ATOGas Utilities

Atmos Energy (ATO) Stock Looks Like A Bargain On Fair Value Yet Rich On Earnings

After nearly doubling shareholders' money over the past five years, Atmos Energy now trades around US$171 per share. The valuation picture is mixed, since the stock screens as undervalued on market multiples but only earns a mid range score on broader checks. Atmos Energy has returned 97.7% over five years, which puts recent valuation questions into the context of a strong long term run. Expectations around steady regulated cash flows can support the current pricing, while any increase in...
NYSE:PG
NYSE:PGHousehold Products

Is Swiffer’s Hair Magnet Collaboration a Clue to P&G’s (PG) Next Phase of Innovation-Led Branding?

Earlier this year, Swiffer, a Procter & Gamble brand, partnered with hair expert Jen Atkin to launch the Swiffer Hair Magnet, a floor-cleaning tool using 3D fluffy fibers and a 360-degree swivel head to capture hair, dust and debris in hard-to-reach areas. This collaboration highlights how P&G is using expert endorsements and product-specific engineering to address everyday household pain points like human and pet hair buildup. Next, we’ll examine how this expert-backed Swiffer Hair Magnet...
NasdaqGS:ERIE
NasdaqGS:ERIEInsurance

Erie Indemnity (ERIE) Stock Looks Near Fair Value But Above Fair Value On Earnings

Erie Indemnity’s share price has delivered a 67.8% return over the past 5 years, yet recent valuation work suggests the stock is not an obvious bargain, with the Excess Returns intrinsic value estimate close to the current market price while earnings based multiples indicate a premium. A 67.8% gain over 5 years highlights that long term holders of Erie Indemnity have already seen a strong payoff, which can limit the margin of safety for new buyers. Future revenue and fee income growth from...
NYSE:HPQ
NYSE:HPQTech

HP (HPQ) Launches Care Complete, Is The Stock Overvalued Or Undervalued?

HP (HPQ) is drawing fresh attention after partnering with Asurion to launch HP Care Complete, a subscription based device protection and support offering that is now available to U.S. customers across PCs and connected home devices. See our latest analysis for HP. HP shares have gained momentum recently, with a 30 day share price return of 23.62% and a 90 day share price return of 36.71%, while the 1 year total shareholder return sits at 18.91%. If this shift toward services and device...
NasdaqGS:CORZ
NasdaqGS:CORZSoftware

Oracle Stock And 2 Crypto Infrastructure Names Tied To AI Data Center Demand

Global demand for AI related technology is lifting export orders for key chip and electronics hubs, and that ripple effect reaches straight into cryptocurrency and blockchain stocks. When more computing power and data infrastructure are built, blockchains and digital asset platforms often gain fresh attention from capital. This article highlights three stocks from our Top Cryptocurrency and Blockchain Stocks screener that could help you position for that trend. The three stocks in this...
NasdaqGS:ONC
NasdaqGS:ONCBiotechs

BeOne Medicines (ONC) Stock May Be Rich After BRUKINSA Access Renewal

BeOne Medicines stock has produced a strong 85.8% return over the past three years, yet the current valuation checks and market multiples suggest the shares are not an obvious bargain at today’s price. The 85.8% three year return signals that BeOne Medicines has already delivered substantial gains for long term holders, so fresh capital is now facing a very different entry point. Recent agreements to expand access to BRUKINSA and to collaborate on RAS inhibitor development can support long...
NYSE:KRC
NYSE:KRCOffice REITs

CFO Shakeup and Insider Interim Appointment Could Be A Game Changer For Kilroy Realty (KRC)

Kilroy Realty Corporation recently disclosed that on August 11, 2026, Chief Financial Officer, Executive Vice President, and Treasurer Jeffrey Kuehling was terminated without Cause under his 2024 employment agreement, with the company emphasizing that his exit was unrelated to any disagreements over financial policies, accounting practices, or disclosures. At the same time, long-time insider and current Chief Investment Officer Eliott Trencher, who previously served as CFO, stepped in as...
NYSE:DHI
NYSE:DHIConsumer Durables

D.R. Horton’s Index Removal and Softer Trends Could Be A Game Changer For DHI

In August 2026, D.R. Horton, Inc. was removed from the Philippines All Share Index after a period of softer quarterly results, declining backlog and orders, and a marked reduction in return on invested capital. This combination of weaker operating trends and loss of index inclusion highlights mounting questions about the homebuilder’s ability to sustain prior levels of profitable growth and new business momentum. We’ll now examine how D.R. Horton’s weaker backlogs and index removal may...
NYSE:TR
NYSE:TRFood

Tootsie Roll Industries (TR) Posts Mixed Quarter, Is The Premium Already Priced In?

Tootsie Roll Industries (TR) reported second quarter 2026 results that drew investor focus, with slightly higher sales and broadly stable revenue, alongside lower net income and earnings per share compared with the prior year period. See our latest analysis for Tootsie Roll Industries. Despite lower earnings in the quarter, Tootsie Roll Industries' recent news sits against a share price that has gained 5.71% over the past month and delivered a 57.45% five year total shareholder return. This...
NasdaqGS:MNDY
NasdaqGS:MNDYSoftware

Atlassian Stock And 2 SMB Software Picks After Harvest Price Hikes

Bending Spoons’ steep Harvest price hikes have jolted the usually sleepy world of SMB time-tracking and invoicing tools, and that ripple now touches a wider group of listed software stocks. Forced migrations and shaken customer trust can reshape who wins and who loses. This article walks through three stocks from our Competing SMB time-tracking and invoicing SaaS screener that appear positioned to benefit from this shake up and explains why they may deserve a closer look. The three stocks...
NasdaqGS:SMCI
NasdaqGS:SMCITech

Super Micro Computer (SMCI) Clears Senior Management And Tightens Export Compliance

Super Micro Computer (NasdaqGS: SMCI) reports that an independent Board-led investigation found no evidence that senior management was involved in alleged illegal diversion of Nvidia-powered servers to China. The company says non-compliant employees have been terminated and additional export control and compliance measures are being adopted following the internal review. The findings address a recent source of regulatory concern for investors focused on export controls in high performance...
NasdaqGS:FRMI
NasdaqGS:FRMISpecialized REITs

AI Data Center REITs Facing Political Risk Before The 2026 Midterms

AI data centers have shifted from quiet infrastructure projects to headline news, with politicians and communities now questioning their power use, water needs, and tax breaks ahead of the 2026 U.S. midterms. That tension can reshape risks and returns for data center REITs exposed to this buildout. This article unpacks the policy story and examines three stocks closely tied to these debates. The three U.S. data center REITs in this article are just a starting sample. The full screen surfaced...
NYSE:PL
NYSE:PLProfessional Services

Planet (PL) Stock Stays Rich On Sales While Returns Stay Strong

Planet Labs PBC stock has delivered an extremely strong run over the last three years, yet the valuation checks flag the shares as expensive rather than a clear bargain. After such a move, investors are weighing rich market expectations against what the fundamentals so far justify paying for the business. Planet Labs PBC has returned very close to 6x over the past three years, which puts extra focus on whether the current price still leaves much room for further gains. The new national...
NasdaqGM:AXSM
NasdaqGM:AXSMPharmaceuticals

Axsome Therapeutics (AXSM) Stock Still Trades Below Fair Value On Sales

Axsome Therapeutics stock has delivered a very large 5 year gain, yet the current valuation checks point to a more measured picture rather than a clear bargain or clear overvaluation. With the share price now at US$218.20 and recent returns mixed over shorter periods, investors are weighing how much of Axsome Therapeutics' progress is already reflected in the price. Axsome Therapeutics has returned roughly 7.6x over 5 years, which puts extra focus on whether the current price still offers an...
NYSE:EW
NYSE:EWMedical Equipment

Edwards Lifesciences (EW) Stock Looks Above Fair Value As Its 22% Three Year Run Continues

Edwards Lifesciences stock is coming off a 21.6% gain over the past three years, while the latest valuation work suggests it may no longer be an obvious bargain, with the Discounted Cash Flow (DCF) estimate sitting close to the current share price and earnings multiples screening as rich. Edwards Lifesciences has returned 21.6% over three years, which puts more pressure on today’s valuation to be supported by future cash flows. Expectations for ongoing demand in structural heart therapies...
NYSE:BAX
NYSE:BAXMedical Equipment

Baxter International (BAX) Taps John Rogers As Chief Financial Officer

Baxter International (NYSE:BAX) appointed John Rogers as Chief Financial Officer, signaling a major change in its senior leadership team. Rogers brings experience in corporate transformation at large multinational companies, which aligns with Baxter International's ongoing restructuring and operational turnaround efforts. The CFO transition places fresh attention on Baxter International's approach to capital allocation, financial controls, and communication with investors. This kind of...
NasdaqGS:PANW
NasdaqGS:PANWSoftware

Palo Alto Networks (PANW) Launched A New AI Cyber Defense Program

Palo Alto Networks (NasdaqGS:PANW) announced a new multi year global alliance with NTT DATA to support secure AI adoption and cyber resilience for enterprises worldwide. The company expanded its AI security partnership with Zero Networks to provide more consistent security management across customer environments. Palo Alto Networks launched its Frontier AI Critical Defense Program, designed to address AI driven threats to critical infrastructure and sensitive organizations. For a broader...
NYSE:CHD
NYSE:CHDHousehold Products

Is Stronger-Than-Expected Q2 Demand and Higher 2026 Guidance Altering The Investment Case For Church & Dwight (CHD)?

In Q2 2026, Church & Dwight reported stronger-than-expected underlying demand, beating forecasts on organic and net sales and prompting a raised full-year 2026 outlook for net sales, organic sales, adjusted EPS, and gross margins. A key takeaway from this past-quarter update is management’s confidence in the business, reflected in higher guidance across both revenue and profitability metrics. Next, we’ll examine how this upgraded 2026 guidance for sales and margins may influence Church &...
NYSE:SPB
NYSE:SPBHousehold Products

Does Spectrum Brands’ Q3 Loss and Intangible Impairment Reshape The Bull Case For SPB?

Spectrum Brands Holdings, Inc. reported past third-quarter 2026 results showing sales of US$753.3 million and a net loss of US$26.8 million, alongside a US$104.0 million impairment of intangible assets, while maintaining guidance for flat to low single digit reported net sales growth for fiscal 2026. The combination of higher sales but weaker profitability and a sizeable write-down of intangible assets highlights pressure on the quality and sustainability of Spectrum Brands’ earnings...
NasdaqCM:PGY
NasdaqCM:PGYSoftware

Discover 3 Growth Companies With Insider Ownership As High As 34%

In the last week, the United States market has stayed flat, but over the past 12 months, it has risen by 20% with earnings forecasted to grow by 17% annually. In this context of growth and stability, companies with high insider ownership can be particularly appealing as they often reflect strong confidence from those who know the business best.